Outpace Bio is a venture-backed biotechnology company building a platform to create next-generation smart cell therapies. Our world-class scientific team is developing cell therapies that intervene in complex biology in ways that small molecules and biologics cannot. Our rich platform combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety. Our partnership business model will accelerate the clinical validation of our platform and the development of truly curative therapies. We value teamwork, creativity, integrity, rigor, and passion for science.
At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $30M
Founded date: 2020
Investors 6
Date | Name | Website |
27.01.2022 | Mana Ventu... | manaventur... |
- | Breton Cap... | bretoncapi... |
- | WRF Capita... | wrfseattle... |
- | Civilizati... | civilizati... |
- | Playground... | playground... |
14.06.2022 | Playground... | playground... |
Funding Rounds 1
Date | Series | Amount | Investors |
05.04.2021 | Series A | $30M | - |
Mentions in press and media 5
Date | Title | Description | Source |
10.07.2023 | How AI is changing the way scientists engineer drugs, biosen... | RF Diffusion, a deep learning tool, was prompted to generate a new protein (orange) that binds to th... | geekwire.c... |
05.04.2021 | Outpace Bio Raises $30 Million To Design Next Generation Cel... | Marc Lajoie, CEO of OutpaceOutpace Bio Outpace Bio, a spinout from Lyell Immunopharma, has landed $... | forbes.com... |
31.03.2021 | Seattle biotech startup Outpace Bio raises $30M to fight can... | Outpace Bio CEO (Outpace Photo) New funding: Outpace Bio raised a $30 million Series A investment r... | geekwire.c... |
31.03.2021 | Outpace Bio Raises $30M in Series A Funding | Outpace Bio, a Seattle, WA-based biotechnology company building a platform to create next-generation... | finsmes.co... |
- | Outpace Bio | “Home | Outpace” | fastfounde... |